News
Share your Holiday vibe! ESDR challenge
The festive season is almost upon us, and the ESDR wants to share the joy and unique perspectives...
ISID Collegiality Awardee 2025
We are delighted to introduce the recipient of the 2025 ISID Collegiality Award for the JSID...
Congratulations to the Montagna Symposium travel awardees
International (ESDR) Awards, Presented by Dr. Masa Amagai to Caroline Mann Montagna Director’s...
Cristina de Guzman Strong, PhD Appointed Next Editor of JID Innovations
The Society for Investigative Dermatology (SID) and the European Society for Dermatologic...
Acknowledgements
The ESDR would like to extend its gratitude to the Scientific Committee Members, Local Organizing...
Welcoming the New ESDR Executive Team
We are pleased to introduce the newly formed ESDR Executive Team, Curdin CONRAD as President,...
About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.
ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.
JID Latest
- Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of Vitiligo
- Molecular, Histological, and Clinical Effects of Selective TYK2 Inhibition with Zasocitinib (TAK-279) in Patients with Moderate-to-Severe Plaque Psoriasis
- Deciphering how the Cutibacterium acnes “sugar coat” impacts acne vulgaris inflammation
- Mechanism-tuned epigenetic precision in squamous cell carcinoma
- Evidence for keratinocyte-derived microvesicle particles as carriers for the potent lipid mediator platelet-activating factor as effectors for systemic effects associated with many environmental stressors
